Hollsteen
← Teradyne

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 2016: $319M · 10-Q 0001193125-16-589497 filed May 13, 2016Cash and equivalents · Q2 2016: $381M · 10-Q 0001193125-16-680412 filed Aug 12, 2016Cash and equivalents · Q3 2016: $298M · 10-Q 0001193125-16-765452 filed Nov 10, 2016Cash and equivalents · Q4 2016: $308M · 10-K 0001193125-17-064638 filed Mar 1, 2017Cash and equivalents · Q1 2017: $325M · 10-Q 0001193125-17-168243 filed May 12, 2017Cash and equivalents · Q2 2017: $598M · 10-Q 0001193125-17-255654 filed Aug 11, 2017Cash and equivalents · Q3 2017: $419M · 10-Q 0001193125-17-338478 filed Nov 9, 2017Cash and equivalents · Q4 2017: $430M · 10-K 0001193125-18-066579 filed Mar 1, 2018Cash and equivalents · Q1 2018: $638M · 10-Q 0001193125-18-160479 filed May 11, 2018Cash and equivalents · Q2 2018: $480M · 10-Q 0001193125-18-245633 filed Aug 10, 2018Cash and equivalents · Q3 2018: $814M · 10-Q 0001193125-18-323422 filed Nov 9, 2018Cash and equivalents · Q4 2018: $927M · 10-K 0001193125-19-059974 filed Mar 1, 2019Cash and equivalents · Q1 2019: $484M · 10-Q 0001193125-19-143836 filed May 10, 2019Cash and equivalents · Q2 2019: $495M · 10-Q 0001193125-19-217772 filed Aug 9, 2019Cash and equivalents · Q3 2019: $594M · 10-Q 0001193125-19-288119 filed Nov 8, 2019Cash and equivalents · Q4 2019: $774M · 10-K 0001193125-20-058676 filed Mar 2, 2020Cash and equivalents · Q1 2020: $593M · 10-Q 0001193125-20-132242 filed May 4, 2020Cash and equivalents · Q2 2020: $725M · 10-Q 0001193125-20-207892 filed Aug 3, 2020Cash and equivalents · Q3 2020: $945M · 10-Q 0001193125-20-283796 filed Nov 2, 2020Cash and equivalents · Q4 2020: $914M · 10-K 0001193125-21-050735 filed Feb 22, 2021Cash and equivalents · Q1 2021: $831M · 10-Q 0001193125-21-154707 filed May 7, 2021Cash and equivalents · Q2 2021: $954M · 10-Q 0001193125-21-238886 filed Aug 6, 2021Cash and equivalents · Q3 2021: $1.1B · 10-Q 0001193125-21-321554 filed Nov 5, 2021Cash and equivalents · Q4 2021: $1.1B · 10-K 0001193125-22-049828 filed Feb 23, 2022Cash and equivalents · Q1 2022: $795M · 10-Q 0001193125-22-143504 filed May 6, 2022Cash and equivalents · Q2 2022: $572M · 10-Q 0001193125-22-213485 filed Aug 5, 2022Cash and equivalents · Q3 2022: $711M · 10-Q 0001193125-22-277821 filed Nov 4, 2022Cash and equivalents · Q4 2022: $855M · 10-K 0001193125-23-044711 filed Feb 22, 2023Cash and equivalents · Q1 2023: $649M · 10-Q 0001193125-23-136994 filed May 5, 2023Cash and equivalents · Q2 2023: $613M · 10-Q 0001193125-23-203780 filed Aug 4, 2023Cash and equivalents · Q3 2023: $637M · 10-Q 0000950170-23-058679 filed Nov 3, 2023Cash and equivalents · Q4 2023: $758M · 10-K 0000950170-24-018701 filed Feb 22, 2024Cash and equivalents · Q1 2024: $707M · 10-Q 0000950170-24-052761 filed May 3, 2024Cash and equivalents · Q2 2024: $422M · 10-Q 0000950170-24-089858 filed Aug 2, 2024Cash and equivalents · Q3 2024: $510M · 10-Q 0000950170-24-119923 filed Nov 1, 2024Cash and equivalents · Q4 2024: $553M · 10-K 0000950170-25-023784 filed Feb 20, 2025Cash and equivalents · Q1 2025: $476M · 10-Q 0000950170-25-062503 filed May 2, 2025Cash and equivalents · Q2 2025: $339M · 10-Q 0000950170-25-101248 filed Aug 1, 2025Cash and equivalents · Q3 2025: $273M · 10-Q 0001193125-25-258477 filed Oct 30, 2025Cash and equivalents · Q4 2025: $294M · 10-K 0001193125-26-059002 filed Feb 19, 2026Cash and equivalents · Q1 2026: $242M · 10-Q 0001193125-26-201058 filed May 1, 2026Cash and equivalents · Q2 2026: $350M · 10-Q 0001193125-26-327715 filed Jul 31, 20262943503191,122Q1 2016Q2 2026
Q4 2025
294$M
All values (42)
PeriodValue ($M)Status
Q2 2026350reported
Q1 2026242reported
Q4 2025294reported
Q3 2025273reported
Q2 2025339reported
Q1 2025476reported
Q4 2024553reported
Q3 2024510reported
Q2 2024422reported
Q1 2024707reported
Q4 2023758reported
Q3 2023637reported
Q2 2023613reported
Q1 2023649reported
Q4 2022855reported
Q3 2022711reported
Q2 2022572reported
Q1 2022795reported
Q4 20211,122reported
Q3 20211,079reported
Q2 2021954reported
Q1 2021831reported
Q4 2020914reported
Q3 2020945reported
Q2 2020725reported
Q1 2020593reported
Q4 2019774reported
Q3 2019594reported
Q2 2019495reported
Q1 2019484reported
Q4 2018927reported
Q3 2018814reported
Q2 2018480reported
Q1 2018638reported
Q4 2017430reported
Q3 2017419reported
Q2 2017598reported
Q1 2017325reported
Q4 2016308reported
Q3 2016298reported
Q2 2016381reported
Q1 2016319reported

CSV with all sources · Technical ID: cash

More metrics for Teradyne
Sources & calculation
Value
$294M
Period
Q4 2025, ended Dec 31, 2025 · as of Dec 31, 2025 (balance as of date, not a sum)
Source
10-K, filed Feb 19, 2026 · 0001193125-26-059002
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$294MFeb 19, 202610-K 0001193125-26-059002reported · confidence 1. · current